ABT — ABBOTT LABORATORIES

Ownership history in Baker Chad R · 36 quarters on record

This page tracks every 13F SEC filing in which Baker Chad R reported a position in ABBOTT LABORATORIES (ABT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

3.22% (2022 Q4)

Avg. % of fund

2.48%

First filed

2017 Q1

Last filed

2025 Q4

Quarters held

36

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	REDUCED	106,735	-845	-0.8%	2.41%	$13.4M	$124.66
2025 Q3	REDUCED	107,580	-100	-0.1%	2.48%	$14.4M	$132.67
2025 Q2	UNCHANGED	107,680	—	0%	2.72%	$14.6M	$134.12
2025 Q1	ADDED	107,680	+455	+0.4%	2.91%	$14.3M	$130.21

% of Fund (quarterly) ABT price (monthly, adj. close)

Other funds also holding ABT

As of 2025 Q4 — sorted by position size

Livelsberger Financial Advisory 16.33% CURA WEALTH ADVISORS, LLC 10.82% PATRICK M SWEENEY & ASSOCIATES, INC 5.83% Sugar Maple Asset Management, LLC 5.64% Milestone Resources Group Ltd 3Y 7Y 5.58% COERENTE CAPITAL MANAGEMENT 3Y 5.06% Tandem Investment Advisors, Inc. 3Y 7Y 4.63% America First Investment Advisors, LLC 3Y 7Y 4.54% HENDLEY & CO INC 3Y 7Y 4.45% Bruce & Co., Inc. 3Y 7Y 4.42%

← Back to Baker Chad R Holdings